+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07206628

Observational Study of Medication Adherence Using CONNECTDROP4 in Patients with Glaucoma or Ocular Hypertension

Led by Laboratoires Thea · Updated on 2026-08-17

200

Participants Needed

15

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a real-life, national, multicenter, prospective study to observe how well patients with glaucoma or ocular hypertension OHT stick to their eye drop treatment using the connected device CONNECTDROP4. The study aims to measure the average yearly adherence rate, understand each patients adherence pattern, and explore how these adherence profiles relate to clinical data. Participants will use the CONNECTDROP4 device clipped onto an EASYGRIP4 eye drop bottle along with a smartphone app daily. This setup helps track the use of intraocular pressure IOP lowering eye drops over a one-year period. The study does not involve any experimental treatments but focuses on monitoring medication adherence in typical care settings. During the study, participants adherence rates are continuously recorded from the start until 12 months later. Researchers will analyze this data alongside clinical information to assess patterns and associations. The study provides a detailed view of how patients manage their glaucoma or OHT therapy in everyday life, with no intervention beyond regular treatment and device use.

CONDITIONS

Brief Title

Real-world Study to Assess Adherence to IOP Lowering Therapy in Patients With Glaucoma or Ocular Hypertension Using CONNECTDROP®

Research Team

M

Medical Operation Manager

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here